Company / Accounts Receivable
Core Scientific, Inc./tx Accounts Receivable History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$1.0M
FY2024
5-year range
$234.0K / $1.4M
FY2021-FY2024
Trend
+2.4%
vs FY2023
Sector context
#98 of 98
Financials
What the data says
Among 98 Financials companies, Core Scientific, Inc./tx is in the bottom 0% for accounts receivable. Improved from $234,000 to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2024 with a 3-year CAGR of -9.5%.
Improved from $234,000 to $1M over the past 2 years.
Financials sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -9.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in FinancialsTop 100% of 98This company $1.0M Sector average $998.1M
▼
-99.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -9.5%, indicating a declining trend.
- In FY2024, accounts receivable increased 2.4% year-over-year.
- Ranks #98 out of 98 companies in the Financials sector.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.0M | +2.4% |
| FY2023 | $1.0M | +327.8% |
| FY2022 | $234.0K | -83.1% |
| FY2021 | $1.4M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026